In-vivo concentration ratio estimation of two fluorescent probes for early detection of Alzheimer's Disease

Osnat Harbater, Israel Gannot

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

In-vivo measurement of the concentrations of biological compounds using fluorescence is one of the challenging biophotonic fields. These measurements are useful in diagnostic and treatment monitoring applications that use fluorescent probes which may bond to specific proteins and drugs. In some cases the relative concentration of two compounds is a sufficient biological indicator. For instance, it has been shown that the ratio between Amyloid-Beta and tau protein in the Cerebrospinal fluid (CSF) may predict the development of Alzheimer's disease (AD) several years before current diagnosis. We have previously suggested a system that could measure the concentration ratio of these two proteins in-vivo without the need to collect CSF samples. This system uses a miniature needle with an optical fiber which is coupled to a laser source and a detector. The fiber excites fluorescent probes which were injected and bond to the proteins in the CSF, and collects the fluorescence emission. Using the fluorescence intensity ratio, the concentration ratio between the proteins is estimated, and AD may be diagnosed. In this work we present the results of an in-vivo trial performed on mice. Miniature tubes containing two fluorescent probes in several concentration ratios were inserted into the mice in two locations: subcutaneously, and deeper in the abdomen. The fluorescent probes were excited and the fluorescence intensity was measured. The concentration ratios were extracted from the fluorescence intensities using a simple calibration curve. The extracted ratios are compared to the true ratios and the system's accuracy is estimated.

Original languageEnglish (US)
Title of host publicationOptical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV
EditorsIsrael Gannot
PublisherSPIE
ISBN (Electronic)9781628414073
DOIs
StatePublished - Jan 1 2015
Externally publishedYes
EventOptical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV - San Francisco, United States
Duration: Feb 7 2015Feb 8 2015

Publication series

NameProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume9317
ISSN (Print)1605-7422

Conference

ConferenceOptical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV
CountryUnited States
CitySan Francisco
Period2/7/152/8/15

Fingerprint

Fluorescent Dyes
Early Diagnosis
Alzheimer Disease
Cerebrospinal fluid
Fluorescence
cerebrospinal fluid
Proteins
probes
proteins
fluorescence
Cerebrospinal Fluid
mice
Cerebrospinal Fluid Proteins
Optical Fibers
tau Proteins
Amyloid beta-Peptides
abdomen
Needles
Abdomen
Calibration

Keywords

  • Alzheimer
  • Concentration measurements
  • CSF
  • Disease Markers
  • Fluorescence
  • In-vivo
  • Light scattering

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Harbater, O., & Gannot, I. (2015). In-vivo concentration ratio estimation of two fluorescent probes for early detection of Alzheimer's Disease. In I. Gannot (Ed.), Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV [931709] (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 9317). SPIE. https://doi.org/10.1117/12.2084550

In-vivo concentration ratio estimation of two fluorescent probes for early detection of Alzheimer's Disease. / Harbater, Osnat; Gannot, Israel.

Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV. ed. / Israel Gannot. SPIE, 2015. 931709 (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 9317).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Harbater, O & Gannot, I 2015, In-vivo concentration ratio estimation of two fluorescent probes for early detection of Alzheimer's Disease. in I Gannot (ed.), Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV., 931709, Progress in Biomedical Optics and Imaging - Proceedings of SPIE, vol. 9317, SPIE, Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV, San Francisco, United States, 2/7/15. https://doi.org/10.1117/12.2084550
Harbater O, Gannot I. In-vivo concentration ratio estimation of two fluorescent probes for early detection of Alzheimer's Disease. In Gannot I, editor, Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV. SPIE. 2015. 931709. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE). https://doi.org/10.1117/12.2084550
Harbater, Osnat ; Gannot, Israel. / In-vivo concentration ratio estimation of two fluorescent probes for early detection of Alzheimer's Disease. Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV. editor / Israel Gannot. SPIE, 2015. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE).
@inproceedings{57c53072e91740c3bfea005c49f4f37d,
title = "In-vivo concentration ratio estimation of two fluorescent probes for early detection of Alzheimer's Disease",
abstract = "In-vivo measurement of the concentrations of biological compounds using fluorescence is one of the challenging biophotonic fields. These measurements are useful in diagnostic and treatment monitoring applications that use fluorescent probes which may bond to specific proteins and drugs. In some cases the relative concentration of two compounds is a sufficient biological indicator. For instance, it has been shown that the ratio between Amyloid-Beta and tau protein in the Cerebrospinal fluid (CSF) may predict the development of Alzheimer's disease (AD) several years before current diagnosis. We have previously suggested a system that could measure the concentration ratio of these two proteins in-vivo without the need to collect CSF samples. This system uses a miniature needle with an optical fiber which is coupled to a laser source and a detector. The fiber excites fluorescent probes which were injected and bond to the proteins in the CSF, and collects the fluorescence emission. Using the fluorescence intensity ratio, the concentration ratio between the proteins is estimated, and AD may be diagnosed. In this work we present the results of an in-vivo trial performed on mice. Miniature tubes containing two fluorescent probes in several concentration ratios were inserted into the mice in two locations: subcutaneously, and deeper in the abdomen. The fluorescent probes were excited and the fluorescence intensity was measured. The concentration ratios were extracted from the fluorescence intensities using a simple calibration curve. The extracted ratios are compared to the true ratios and the system's accuracy is estimated.",
keywords = "Alzheimer, Concentration measurements, CSF, Disease Markers, Fluorescence, In-vivo, Light scattering",
author = "Osnat Harbater and Israel Gannot",
year = "2015",
month = "1",
day = "1",
doi = "10.1117/12.2084550",
language = "English (US)",
series = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",
publisher = "SPIE",
editor = "Israel Gannot",
booktitle = "Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV",

}

TY - GEN

T1 - In-vivo concentration ratio estimation of two fluorescent probes for early detection of Alzheimer's Disease

AU - Harbater, Osnat

AU - Gannot, Israel

PY - 2015/1/1

Y1 - 2015/1/1

N2 - In-vivo measurement of the concentrations of biological compounds using fluorescence is one of the challenging biophotonic fields. These measurements are useful in diagnostic and treatment monitoring applications that use fluorescent probes which may bond to specific proteins and drugs. In some cases the relative concentration of two compounds is a sufficient biological indicator. For instance, it has been shown that the ratio between Amyloid-Beta and tau protein in the Cerebrospinal fluid (CSF) may predict the development of Alzheimer's disease (AD) several years before current diagnosis. We have previously suggested a system that could measure the concentration ratio of these two proteins in-vivo without the need to collect CSF samples. This system uses a miniature needle with an optical fiber which is coupled to a laser source and a detector. The fiber excites fluorescent probes which were injected and bond to the proteins in the CSF, and collects the fluorescence emission. Using the fluorescence intensity ratio, the concentration ratio between the proteins is estimated, and AD may be diagnosed. In this work we present the results of an in-vivo trial performed on mice. Miniature tubes containing two fluorescent probes in several concentration ratios were inserted into the mice in two locations: subcutaneously, and deeper in the abdomen. The fluorescent probes were excited and the fluorescence intensity was measured. The concentration ratios were extracted from the fluorescence intensities using a simple calibration curve. The extracted ratios are compared to the true ratios and the system's accuracy is estimated.

AB - In-vivo measurement of the concentrations of biological compounds using fluorescence is one of the challenging biophotonic fields. These measurements are useful in diagnostic and treatment monitoring applications that use fluorescent probes which may bond to specific proteins and drugs. In some cases the relative concentration of two compounds is a sufficient biological indicator. For instance, it has been shown that the ratio between Amyloid-Beta and tau protein in the Cerebrospinal fluid (CSF) may predict the development of Alzheimer's disease (AD) several years before current diagnosis. We have previously suggested a system that could measure the concentration ratio of these two proteins in-vivo without the need to collect CSF samples. This system uses a miniature needle with an optical fiber which is coupled to a laser source and a detector. The fiber excites fluorescent probes which were injected and bond to the proteins in the CSF, and collects the fluorescence emission. Using the fluorescence intensity ratio, the concentration ratio between the proteins is estimated, and AD may be diagnosed. In this work we present the results of an in-vivo trial performed on mice. Miniature tubes containing two fluorescent probes in several concentration ratios were inserted into the mice in two locations: subcutaneously, and deeper in the abdomen. The fluorescent probes were excited and the fluorescence intensity was measured. The concentration ratios were extracted from the fluorescence intensities using a simple calibration curve. The extracted ratios are compared to the true ratios and the system's accuracy is estimated.

KW - Alzheimer

KW - Concentration measurements

KW - CSF

KW - Disease Markers

KW - Fluorescence

KW - In-vivo

KW - Light scattering

UR - http://www.scopus.com/inward/record.url?scp=84928550781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928550781&partnerID=8YFLogxK

U2 - 10.1117/12.2084550

DO - 10.1117/12.2084550

M3 - Conference contribution

AN - SCOPUS:84928550781

T3 - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

BT - Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XV

A2 - Gannot, Israel

PB - SPIE

ER -